Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements
November 09, 2023 16:05 ET
|
Tarsus Pharmaceuticals, Inc
Launched XDEMVY® (lotilaner ophthalmic solution) 0.25%, for the treatment of Demodex blepharitis Achieved $1.7 million in net product sales with more than 1,700 dispensed bottles Strengthened...
Solid Biosciences Provides Third Quarter Business Update and Financial Results
November 08, 2023 16:17 ET
|
Solid Biosciences Inc.
– IND submission for SGT-003 for patients with Duchenne muscular dystrophy in Q4 2023 – – Strengthened management team with appointment of Dr. Gabriel Brooks as CMO – – Company ends third quarter...
Spherix Global Insights Amplifies the Lupus Patient Voice, Highlighting the Lengthy and Challenging Journey to Diagnosis and Treatment
November 08, 2023 15:37 ET
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 08, 2023 (GLOBE NEWSWIRE) -- [Exton PA, November 8, 2023] — Spherix Global Insights recently conducted research with 306 Systemic Lupus Erythematosus (SLE) patients,...
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
November 08, 2023 05:45 ET
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC and AVANIA CRO CONTRACT to GUIDE the DEVELOPMENT of TWO DRUG THERAPIES and the RETINALCAM™ IMAGE VISUALIZATION DEVICE
US Neurologists Emphasize Tremendous Unmet Treatment Need in Parkinson's Disease, According to Spherix Global Insights
November 07, 2023 10:41 ET
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Parkinson's disease (PD) is the second-most prevalent neurodegenerative disorder following Alzheimer's disease, affecting an estimated one...
New Preliminary Clinical Data on Potential of Opus AAV-based Gene Therapy for Rare Inherited Retinal Disease to be Presented at the American Academy of Ophthalmology Annual Conference 2023
November 03, 2023 15:43 ET
|
Opus Genetics
RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-focused gene therapy company developing treatments for inherited retinal diseases, today announced that preliminary data...
Claritas HealthTech Announces the Spin-Off of Intelligent Scopes Corp for Strategic Growth and Focused Delivery of Precision AI Diagnostic Solutions for Urology and Gastroenterology
November 03, 2023 14:18 ET
|
Claritas HealthTech Ltd
Claritas HealthTech Announces the Spin-Off of Intelligent Scopes Corp for Focused Delivery of AI Diagnostic Tools for Urology and Gastroenterology
Alkeus Pharmaceuticals Presents Positive Gildeuretinol Trial Results at American Academy of Ophthalmology, Demonstrating Significant Slowing of Retinal Atrophic Lesions in Stargardt Disease
November 03, 2023 12:00 ET
|
Alkeus Pharmaceuticals
Primary endpoint met, demonstrating a 21% slowing (p<0.001) in the growth rate of atrophic retinal lesions compared to the untreated arm; 28% reduction (p<0.001) using observed atrophic...
Ora, Inc. and BlindCAN Film Festival Unveil The Blind Canvas Project Using AI to Visualize the Human Experience of Blindness
November 03, 2023 08:00 ET
|
Ora, Inc.
Stories, art, and artificial intelligence cultivate awareness andcelebrate individuals living with visual impairments A Media Snippet accompanying this announcement is available by clicking on this...
RxSight, Inc. Educational and Product Announcements for AAO 2023
November 02, 2023 09:00 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- November 2, 2023 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...